PitchSend

Investor Presentaiton

Investor Presentation First nine months of 2018 Slide 80 The GLP-1 segment accounts for around 1% of the total diabetes care market value in Region China VictozaⓇ value market share in Region China Chinese GLP-1 market GLP-1 value in bDKK VictozaⓇ Exenatide Share of total diabetes care GLP-1 value market share market 100% 0.20 1.5% CAGR value¹: 32.5% 80% 0.15 1.0% 60% 0.10 0.05 0.00 Aug 2013 1 CAGR for 5-year period Source: IQVIA monthly MAT Aug, 2018 value figures (DKK) changing diabetes 40% 0.5% 20% 0.0% 0% Aug 2018 Aug 2013 Victoza® Source: IQVIA monthly MAT Aug, 2018 value figures (DKK), market share does not add up to 100% due to rounding Exenatide Aug 2018 .82% 17% novo nordisk

View entire presentation